Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 201 of 1,261

  1. WO 2023054310

    ENSEMBLE DE PERFUSION GOUTTE-À-GOUTTE INTRAVEINEUX POURVU D'UN FILTRE DE PERFUSION À ÉVENT D'AIR

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Apr 6, 2023 · Expires Apr 1, 2043

    granted

  2. US 11617742

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  3. US 11617761

    Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

    The Regents of the University of California · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  4. US 11617793

    Anhydrous sodium thiosulfate and formulations thereof

    Fennec Pharmaceuticals, Inc. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  5. US 11617755

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  6. US 11617756

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  7. US 11617753

    Methods of treating and inhibiting Ebola virus infection

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  8. US 11617770

    Sporeforming probiotic strains, methods and uses thereof

    CIIMAR—CENTRO INTERDISCIPLINAR DE INVESTIGACAO MARINHA E AMBIENTAL · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  9. US 11617791

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  10. US 11617796

    Conjugate of minoxidil and peptide

    CAREGEN CO., LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  11. US 11617769

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  12. US 11617771

    Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto

    The Regents of the University of California · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  13. US 11618746

    Inhibitors of APOL1 and methods of using same

    Vertex Pharmaceuticals Incorporated · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  14. US 11618784

    Anti-CD47 combination therapy

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  15. US 11617800

    Nanoparticle-enhanced activity of a potassium channel-blocking peptide

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  16. US 11618731

    Prodrugs of kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  17. US 11618888

    Tumor-selective E1A and E1B mutants

    The Regents of the University of California · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  18. US 11617766

    Notch receptors with hinge domain

    The Regents of the University of California · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  19. US 11617788

    Viral promoters and compositions and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  20. US 11617801

    RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  21. US 11618733

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  22. CA 3230895

    TRAITEMENTS AVEC DES COMPOSES PTH A ACTION PROLONGEE

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Mar 30, 2023 · Expires Mar 25, 2043

    granted

  23. AU 2021319613

    Antimicrobial peptidomimetics

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Mar 30, 2023 · Expires Mar 25, 2043

    granted

  24. AU 2021323364

    Antimicrobial peptidomimetics

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Mar 30, 2023 · Expires Mar 25, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.